TRUDY H SANSON
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism WEST MONROE, LA NPI 1104889781
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism LA Corcept Therapeutics All categories
General Payments — all program years on this page
$1,360.72
- Category: General Payments
- Program years: PY2018–2024
- Record count: 67
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $177.79 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $177.79 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Corcept Therapeutics | $24.91 | 1 |
| Amgen Inc. | $23.51 | 1 |
| IBSA Pharma Inc. | $22.87 | 1 |
| ABBVIE INC. | $22.36 | 1 |
| Xeris Pharmaceuticals, Inc. | $22.32 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $22.13 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $21.68 | 1 |
| Lilly USA, LLC | $18.01 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086141373 | Bayer Healthcare Pharmaceuticals Inc. | $22.13 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1106017059 | ABBVIE INC. | $22.36 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116086971 | Amgen Inc. | $23.51 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117740006 | Corcept Therapeutics | $24.91 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135485587 | Lilly USA, LLC | $18.01 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139166175 | RECORDATI_RARE_DISEASES_INC. | $21.68 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142984542 | IBSA Pharma Inc. | $22.87 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144616383 | Xeris Pharmaceuticals, Inc. | $22.32 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.